Allied Market Research

2024

Active Pharmaceutical Ingredients Market

Active Pharmaceutical Ingredients Market Size, Share, Competitive Landscape and Trend Analysis Report, by API Type, by Drug Type, by by Therapy Area, by End User and Region: Global Opportunity Analysis and Industry Forecast, 2023-2033

LS : Pharmaceuticals

Select an option
Author's: | Roshan Deshmukh
Publish Date:

Get Sample to Email

Increase in Abbreviated New Drug Applications (ANDA) over the past years has fostered the demand for API market. Furthermore, Indian companies making increased entries related to Drug Master File (DMF) indicates APIs market gaining traction. Stringent regulatory policies in the European Union is likely to restrain market growth. Patent expiry of biological drugs creates new growth opportunities for key API manufacturers.

The report segments the market on the basis of synthesis, type of manufacturer, type and therapy. Based on synthesis, this market is segmented into synthetic API and biotech API. The former is further segmented into Innovative synthetic APIS and generic synthetic APIS, while the latter is further segmented on the basis of products and type. The biotech APIS market, by product is further segmented into monoclonal antibodies, recombinant proteins and vaccines. On the basis of type of manufacturer, this market is segmented into captive API manufacturers, merchant API manufacturers, innovative APIS and generic APIS. On the basis of type, the market is segmented into innovative APIS segment and generic APIS segment. On the basis of therapy, the market is segmented into oncology, diabetes, cardiovascular disease, Cns and neurological disorders, orthopedic disorders, nephrology, ophthalmology, pulmonology, gastrointestinal disorders and endocrinology.

On the basis of geography, the market is segmented into North America, Europe, Asia-Pacific, and Latin America, Middle East & Africa (LAMEA).

Key market players in this market are Teva Pharmaceutical Industries Limited, Dr. Reddys Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Novartis International AG, Albemarle Corporation, Sigma-Aldrich Corporation, Mylan Inc., and Allergan PLC

KEY BENEFITS FOR STAKEHOLDERS:

  • The report provides a comprehensive analysis of current & future market trends, key market challenges and emerging avenues for the growth of this market globally.
  • The report offers latest technological innovations and the recent R&D developments.
  • The report offers an insight into competitive landscape in terms of new technological developments, untapped segments, and value chain analysis.
  • This report entails the detailed quantitative analysis of the current market and estimations which assists in identifying the prevailing market opportunities.
  • The report offers detailed segmentation and analyzes the key segments in terms of market size by value and volume and country-level analysis to provide an in-depth understanding of the market.
  • Porters Five Forces analysis is offered in the report along with highlighting bargaining power of buyers and suppliers.
  • The report offers strategic analysis of financial status of key market players, and highlights market share of key vendors.
  • The report offers information on the status of new projects along with offering investment feasibility analysis of the same.

Active Pharmaceutical Ingredients Market Report Highlights

Aspects Details
icon_5
By API Type
  • Chemical API
  • Biological API
icon_6
By Drug Type
  • Prescription
  • Over-the-counter (OTC) Drugs
icon_7
By Therapy Area
  • Cardiovascular Drugs
    • Amlodipine
    • Atenolol
    • Metoprolol Succinate
    • Furosemide
  • Oncology Drugs
    • Fluconazole
    • Ketoconazole
    • Montelukast Sodium
    • Sumatriptan Succinate
  • Neurology Drugs
    • Gabapentin
    • Levocetirizine dihydrochloride
    • Venlafaxine HCL
    • Donepezil
  • Endocrinology Drugs
    • Glimepiride
    • Metformin HCL
    • Levothyroxine
    • Pioglitazone
  • Gastroenterology Drugs
    • Bisacodyl
    • Omeprazole
    • Pantaprazole
    • Loperamide
  • Infectious Diseases Drugs
    • Nitrofurantoin
    • Sulfadoxine
    • Pyrimethamine
    • Ciprofloxacin HCL
  • Respiratory Drugs
    • Ambroxol HCl
    • Bromhexine HCl
    • Terbutaline Sulphate
    • Salbutamol Sulphate
  • Others
    • Sulfadoxine
    • Albendazole
    • Chlorhexidine Gluconate
    • Mebendazole
icon_8
By End User
  • Pharma and Biotechnology Companies
  • Contract Research Organization
  • Contract Manufacturing Organization
icon_9
By Region
  • North America  (U.S., Canada, MEXICO)
  • Europe  (Germany, France, UK, Italy, Spain, Rest of Europe)
  • Asia-Pacific  (Japan, China, Australia, India, South Korea, Rest of Asia-Pacific)
  • LAMEA  (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
icon_10
Key Market Players

AbbVie Inc., Pfizer Inc., Merck KGaA, Sun Pharmaceutical Industries Limited, Dr. Reddy’s Laboratories Ltd., Teva Pharmaceuticals, Cipla, Sandoz, Aurobindo Pharma, Eli Lilly And Company.

Loading Table Of Content...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

Active Pharmaceutical Ingredients Market

Global Opportunity Analysis and Industry Forecast, 2023-2033